CLEVELAND, Ohio (WOIO) -Mono has long-plagued teenagers and young adults, with terrible fatigue and sore throats for weeks, without treatment or cure. A Northeast Ohio doctor’s office is working on a new vaccine that seeks to eradicate mono and the virus …

ModeX Therapeutics Inc., an OPKO Health company, announces dosing of the first participant in the phase I study (NCT06655324) of an Epstein-Barr virus (EBV) vaccine candidate being developed in collaboration with Merck, known as MSD outside the United …

Epstein-Barr virus (EBV) causes infectious mononucleosis and is associated with several types of cancer and multiple sclerosis There are no current treatments or vaccines for EBV First participant dosed with novel investigational EBV vaccine targeting …

The following is a summary of “Self-reported longitudinal COVID-19 vaccination reactogenicity profiles in persons with multiple sclerosis,” published in the December 2024 issue of Neurology by Briggs et al.   Preventing severe COVID-19 outcomes remains …

Breadcrumb Trail Links Opinion Column Life-altering call during pandemic turned Sara Pincott's world upside down. Sara Pincott in this photo prior to her multiple sclerosis diagnosis in January 2022. Photo by Sara Pincott/Supplied photo /jpg, …

Paris: Sanofi has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to tolebrutinib for the treatment of adults with non-relapsing secondary progressive multiple sclerosis (nrSPMS). This is based on …

Tolebrutinib designated Breakthrough Therapy by the FDA for non-relapsing secondary progressive multiple sclerosis Designation is based on positive results from the HERCULES study in adults with non-relapsing secondary progressive multiple sclerosis ( …

… CD20 in multiple sclerosis: pharmacology, efficacy … Vaccine-breakthrough SARS-CoV-2 infections in people with multiple sclerosis … with relapsing multiple sclerosis treated with … multiple sclerosis. Vaccines. 2023;11(5):978. doi:10.3390/vaccines11050978 …

A recent comprehensive review published in Health Science Reports provides an in-depth analysis of the efficacy, safety, and complications associated with COVID-19 vaccines in patients with multiple sclerosis (MS).1 The study, conducted by researchers from …

… Nucleome Therapeutics, Vaccinex Inc., and others are evaluating new multiple sclerosis drugs to … emerging multiple sclerosis pipeline therapies @ Multiple Sclerosis Clinical Trials Multiple Sclerosis Therapeutics Assessment The multiple sclerosis pipeline …